Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Gonytolide A
ID: ALA4468756
Max Phase: Preclinical
Molecular Formula: C32H30O14
Molecular Weight: 638.58
Molecule Type: Unknown
Associated Items:
ID: ALA4468756
Max Phase: Preclinical
Molecular Formula: C32H30O14
Molecular Weight: 638.58
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COC(=O)[C@]1([C@@H]2CCC(=O)O2)CC(=O)c2c(O)cc(C)c(-c3c(C)cc(O)c4c3O[C@@](C(=O)OC)([C@@H]3CCC(=O)O3)CC4=O)c2O1
Standard InChI: InChI=1S/C32H30O14/c1-13-9-15(33)25-17(35)11-31(29(39)41-3,19-5-7-21(37)43-19)45-27(25)23(13)24-14(2)10-16(34)26-18(36)12-32(30(40)42-4,46-28(24)26)20-6-8-22(38)44-20/h9-10,19-20,33-34H,5-8,11-12H2,1-4H3/t19-,20-,31+,32+/m0/s1
Standard InChI Key: JENKJIXLVFFCGZ-PYTHCZBLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 638.58 | Molecular Weight (Monoisotopic): 638.1636 | AlogP: 2.55 | #Rotatable Bonds: 5 |
Polar Surface Area: 198.26 | Molecular Species: NEUTRAL | HBA: 14 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 14 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 8.49 | CX Basic pKa: | CX LogP: 3.92 | CX LogD: 3.88 |
Aromatic Rings: 2 | Heavy Atoms: 46 | QED Weighted: 0.36 | Np Likeness Score: 1.16 |
1. Kikuchi H, Hoshikawa T, Kurata S, Katou Y, Oshima Y.. (2016) Design and Synthesis of Structure-Simplified Derivatives of Gonytolide for the Promotion of Innate Immune Responses., 79 (5): [PMID:27082979] [10.1021/acs.jnatprod.5b00829] |
Source(1):